BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1720054)

  • 1. Challenges of IP chemotherapy for ovarian cancer.
    Anselmo-Murphy AM
    Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):21-2. PubMed ID: 19856604
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.
    Petru E; Benedicic Ch; Huell A
    Gynecol Oncol; 2006 Jul; 102(1):129; author reply 130. PubMed ID: 16600354
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use and nursing of intraperitoneal chemotherapy for ovarian cancer].
    Gao SY; Han JH; Li HY
    Zhonghua Hu Li Za Zhi; 1996 Apr; 31(4):211-2. PubMed ID: 8826214
    [No Abstract]   [Full Text] [Related]  

  • 4. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
    Tropé C; Kaern J; Vergote I
    Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
    [No Abstract]   [Full Text] [Related]  

  • 5. Nursing perspectives on intraperitoneal chemotherapy.
    Hoff ST
    J Intraven Nurs; 1991; 14(5):309-14. PubMed ID: 1748914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal chemotherapy.
    Markman M
    Semin Oncol; 1991 Jun; 18(3):248-54. PubMed ID: 2042064
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraperitoneal therapy in the management of patients with ovarian cancer.
    McClay EF; Howell SB
    Hematol Oncol Clin North Am; 1992 Aug; 6(4):915-26. PubMed ID: 1500393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
    Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
    In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second line chemotherapy of carcinoma of the ovary. Current approaches].
    Sesti F; Mantenuto L; Ciancaglini G; Zupi E; Terenzi S; Piccione E
    G Ital Oncol; 1989; 9(4):121-4. PubMed ID: 2693348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraperitoneal chemotherapy for ovarian carcinoma.
    Markman M
    Biomed Pharmacother; 1987; 41(8):420-4. PubMed ID: 3330457
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.